Percutaneous transluminal alcohol septal myocardial ablation after aortic valve replacement

Catheterization and Cardiovascular Interventions

Volumn 53, Issue 4, 2001, Pages 524-526

  Sitges, Marta ^a   Kapadia, Samir ^a   Rubin, David N ^a   Thomas, James D ^a   Tuzcu, Murat E ^a   Lever, Harry M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Hypertrophic cardiomyopathy; Septal ablation

Indexed keywords

ALCOHOL;

ADULT; AORTA VALVE REPLACEMENT; ARTICLE; CASE REPORT; FEMALE; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART SURGERY; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MINIMALLY INVASIVE SURGERY; NONSURGICAL INVASIVE THERAPY; PERCUTANEOUS TRANSLUMINAL SEPTAL MYOCARDIAL ABLATION; TREATMENT OUTCOME;

NASA DISCIPLINE CARDIOPULMONARY; NON-NASA CENTER;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; AORTIC VALVE; CATHETER ABLATION; ETHANOL; HEART SEPTUM; HEART VALVE PROSTHESIS; HUMANS; MALE; MIDDLE AGED; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 0034905092     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.1215     Document Type: Article

References (6)

1. Regression of left ventricular hypertrophy after aortic valve replacement for aortic stenosis with different valve substitutes
2. Abnormal left ventricular intracavitary flow acceleration in patients undergoing aortic valve replacement for aortic stenosis: A marker for higher postoperative morbidity and mortality
3. Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy
4. Non-surgical septal reduction for hypertrophic obstructive cardiomyopathy: Outcome in the first series of patients
5. Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy
6. New insights into the reduction of mitral valve systolic anterior motion following ventricular septal myectomy in hypertrophic cardiomyopathy